English
Spanish
Learn about Ziextenzo (pegfilgrastim-bmez), the long-acting G-CSF treatment option from Sandoz1
G-CSF=granulocyte colony-stimulating factor.
Reference: 1. ZIEXTENZO Prescribing Information. Sandoz Inc. March 2021.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.
G-CSF=granulocyte colony-stimulating factor.
Reference: 1. ZIEXTENZO Prescribing Information. Sandoz Inc. March 2021.
ZARXIO® (filgrastim-sndz) is contraindicated in patients with a history of serious allergic reactions to human granulocyte colony-stimulating factors such as filgrastim or pegfilgrastim products.
Most common adverse reactions in patients:
Please see full Prescribing Information for ZARXIO.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please choose whether you are a healthcare professional or a patient.